Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tangshen (1 trial)
Diabetic Nephropathies (Phase 1)
Kidney Diseases (Phase 1)
Trials (1 total)
Trial APIs (1 total)